Press Releases

Mar 27, 2026

Caleb Monroe

Press Releases

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

Biogen announced positive Phase 2 results from the AMETHYST study for litifilimab, an investigational monoclonal antibody targeting BDCA2, demonstrating statistically significant improvement in skin disease activity in patients with cutaneous lupus erythematosus (CLE). These consistent positive results, along with a favorable safety profile and FDA…

BIIB

Mar 27, 2026

Derek Hwang

Press Releases

Fusion Fuel Highlights Royal Uranium’s 2% NSR on Two Mineral Claims held by the Shea Creek Joint Venture, One of Canada’s Largest Undeveloped Uranium Projects in the Athabasca Basin

Fusion Fuel Green PLC announced details on its anticipated 2% Net Smelter Return (NSR) royalty on two mineral claims within the Shea Creek Joint Venture, part of a 16-uranium-royalty portfolio expected to be acquired through its pending transaction with Royal Uranium Inc. The Shea Creek project hosts significant undeveloped uranium resources in Can…

HTOO

Mar 27, 2026

Priya Menon

Press Releases

Case IH Celebrates American Farmers At The White House

CNH Industrial's Case IH brand showcased its iconic Heartland Magnum tractor on the White House South Lawn during a presidential event celebrating American agriculture. This one-of-a-kind patriotic tractor symbolizes nearly four decades of manufacturing excellence and CNH's strong commitment to US farming and innovation. CNH Industrial, with a larg…

CNH

Mar 27, 2026

Marcus Reed

Press Releases

Magna Posts 2025 Annual Report

Magna International Inc., a leading global automotive supplier, has published its 2025 Annual Report, including financial statements and management analysis. The company announced its 2026 Annual Meeting of shareholders will be held virtually on May 4, 2026. Magna's reports are accessible on their website and regulatory agencies in Canada and the U…

MGA

Mar 27, 2026

Maya Rios

Press Releases

Electra Restarts Construction and Reports 2025 Financial Results

Electra Battery Materials Corporation announced a successful recapitalization and the restart of construction on its cobalt sulfate refinery in Ontario, with a $73 million board-approved budget targeting mechanical completion in mid-2027 and commercial production by late 2027. The company strengthened its balance sheet via debt-to-equity conversion…

ELBM

Mar 27, 2026

Jordan Park

Press Releases

Manhattan Bridge Capital, Inc. Reports 2025 Results

Manhattan Bridge Capital, Inc., a Nasdaq-listed firm specializing in short-term secured real estate loans, reported net income of approximately $5.11 million for 2025, down 8.6% from 2024 due to lower interest income and a decrease in loan originations. Revenue declined by 10.6% reflecting a contraction in loans receivable and slowed loan originati…

LOAN

Mar 27, 2026

Nina Shah

Press Releases

Preliminary Results for the Year Ended 31 December 2025

Biodexa Pharmaceuticals PLC, a NASDAQ-listed clinical-stage biopharmaceutical company specializing in gastrointestinal cancers, announced its audited preliminary results for the year ended December 31, 2025. Key developments include progress in the Phase 3 Serenta trial of eRapa for Familial Adenomatous Polyposis, initiation of a Phase 2a study of …

BDRX

Mar 27, 2026

Derek Hwang

Press Releases

TRG Latin America Acquisitions Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option

TRG Latin America Acquisitions Corp. announced that its IPO underwriter exercised part of its over-allotment option, purchasing an additional 632,000 units at $10 each. This raises the total units sold to 20,632,000 and gross proceeds to over $206 million, strengthening the company's capital for future business combinations.

TRGSU

Mar 27, 2026

Derek Hwang

Press Releases

Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

Entera Bio reported full year 2025 financial results and significant business updates, highlighting progress in its oral peptide pipeline. The company submitted a streamlined Phase 3 protocol for EB613, its first oral anabolic tablet for osteoporosis, potentially accelerating approval timeline. Collaborations for other oral peptide candidates targe…

ENTX

Mar 27, 2026

Maya Rios

Press Releases

SPAR Group, Inc. Announces Timing of Fiscal 2025 Fourth Quarter and Full Year Results Conference Call

SPAR Group, Inc., a merchandising and marketing services provider in the US and Canada, announced it will release its fourth quarter and full fiscal year 2025 financial results on March 31, 2026, before the market opens. The company will host a conference call featuring its CEO and CFO to discuss the results and answer investor questions.

SGRP

Mar 27, 2026

Leila Farooq

Press Releases

E-Power Inc. and Raytel Electronics Announce Strategic Alliance to Launch Next-Generation 800G and 1.6T High-Speed Optical Modules for U.S. AI Data Centers

E-Power Inc. has announced a strategic alliance with Raytel Electronics to co-develop and launch next-generation 800G and 1.6T high-speed optical modules targeted at the North American AI data center market. By integrating Raytel's optical tech with E-Power's power solutions, the companies aim to deliver optimized connectivity and energy management…

EPOW

Mar 27, 2026

Maya Rios

Press Releases

Atlanta Braves, Gray Media to Simulcast 25 Regular Season Games on Free, Local Over-the-Air Television Stations Across the Southeast

The Atlanta Braves and Gray Media have entered a multi-year agreement to simulcast 25 regular season Braves games on Gray's local television stations across the Southeast, expanding access to free over-the-air broadcasts alongside the Braves' own BravesVision platform. Gray's Raycom Sports will provide production services for BravesVision games. Th…

GTN

Mar 27, 2026

Sofia Navarro

Press Releases

VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering

VisionSys AI Inc., a NASDAQ-listed company specializing in brain-machine interaction technologies, announced a registered direct offering of 3 million American Depositary Shares (ADS) priced at $1.00 per share, aiming to raise approximately $3 million before fees. The offering is subject to customary closing conditions and is expected to close arou…

VSA

Mar 27, 2026

Caleb Monroe

Press Releases

VEON Reinforces Alignment with Shareholder Value Creation

VEON Ltd. highlights strong alignment between management and shareholders through meaningful insider ownership exceeding 1.8% and ongoing disciplined capital allocation, including a substantial $100 million annual share buyback target. The company continues to execute its digital operator strategy across five frontier markets, focusing on sustainab…

VEON

Mar 27, 2026

Jordan Park

Press Releases

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Monopar Therapeutics announced its Q4 and full-year 2025 financial results, highlighting progress toward a planned FDA New Drug Application submission for ALXN1840 to treat Wilson disease. The company strengthened its leadership team and balance sheet through a $91.9 million public offering, and reported reduced net losses compared to 2024. Additio…

MNPR

Mar 27, 2026

Maya Rios

Press Releases

ArcelorMittal announces publication of the 2025 statutory financial statements of ArcelorMittal parent company

ArcelorMittal, a leading global steel and mining company, has published its 2025 statutory financial statements for its parent company. The document is filed with the Luxembourg Stock Exchange and details the company's substantial revenues, production volumes, and commitment to sustainable steelmaking processes.

MT

Mar 27, 2026

Derek Hwang

Press Releases

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

LB Pharmaceuticals announced new positive data from the Phase 2 NOVA-1 trial showing that LB-102, a novel benzamide antipsychotic candidate, directly improves cognitive performance in patients with acute schizophrenia. These findings, presented at the 2026 Schizophrenia International Research Society Congress, support ongoing Phase 3 and additional…

LBRX

Mar 27, 2026

Nina Shah

Press Releases

Allot Files Annual Report on Form 20-F for the Year Ended December 31, 2025

Allot Ltd., a global provider of Security-as-a-Service and network intelligence solutions, announced the filing of its annual report on Form 20-F for the year ended December 31, 2025. The report includes audited financial statements and is available on the SEC and company websites. The company serves over 500 service providers and 1000 enterprises …

ALLT

Mar 27, 2026

Caleb Monroe

Press Releases

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

Celldex Therapeutics presented positive Phase 2 clinical trial results for barzolvolimab in chronic spontaneous urticaria (CSU), cold urticaria (ColdU), and symptomatic dermographism (SD) at the 2026 AAD Annual Meeting. The data demonstrated rapid, profound, and durable improvements in patient quality of life across multiple domains, with sustained…

CLDX

Mar 27, 2026

Priya Menon

Press Releases

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

Aclaris Therapeutics presented additional positive Phase 2a clinical trial results for ATI-2138, an investigational oral inhibitor targeting ITK and JAK3, showing significant improvements in atopic dermatitis severity, itch, and quality of life. The therapy demonstrated strong efficacy and tolerability, supporting its potential in treating immuno-i…

ACRS

Mar 27, 2026

Derek Hwang

Press Releases

Maris-Tech Receives Order to Conduct Situational Awareness Pilot on Armored Vehicle in the United States

Maris-Tech Ltd., a Nasdaq-listed company specializing in AI-based edge computing video solutions for defense, announced it received an order to conduct a situational awareness pilot on an armored vehicle in the U.S. The pilot integrates Maris-Tech's Diamond Ultra platform with night-vision and thermal imaging sensors to enhance battlefield awarenes…

MTEK

Mar 27, 2026

Derek Hwang

Press Releases

Silynxcom Receives a $1.1 Million Purchase Order for Tactical Systems from a Middle East Military Force

Silynxcom Ltd. announced receiving a purchase order exceeding $1.1 million from a long-standing Middle East military customer for its ruggedized tactical communication headset devices. This order underscores the trust in Silynxcom's innovative, combat-proven tactical systems that deliver advanced communication and protective solutions in demanding …

SYNX

Mar 27, 2026

Avery Klein

Press Releases

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

AnaptysBio's Board has approved the spin-off of First Tracks Biotherapeutics, a clinical-stage biotech focused on autoimmune disease therapeutics. The new entity will trade on Nasdaq under ticker TRAX starting April 20, 2026. First Tracks Bio will commence operations with $180 million in cash and a robust leadership team, enabling a focused approac…

ANAB

Mar 27, 2026

Derek Hwang

Press Releases

Kartoon Studios to Release Shareholder Letter and Business Update Including AI Animated Video Featuring Company Executives and Iconic Characters

Kartoon Studios (NYSE American: TOON) will release its annual Shareholder Letter and a groundbreaking AI-animated video business update featuring company executives alongside iconic characters from its upcoming Hundred Acre Wood series. The presentation aims to demonstrate the company's innovative AI-driven animation production capabilities, which …

TOON

Mar 27, 2026

Derek Hwang

Press Releases

United-Guardian Reports 2025 Financial Results

United-Guardian, Inc. reported a 13% decline in net sales for fiscal year 2025 to $10.5 million and a net income drop to $2.1 million, impacted primarily by reduced cosmetic ingredient sales due to distributor inventory excess and weakened demand in China amid tariffs and local competition. Positives include growth in pharmaceutical and medical lub…

UG